Previous studies have indicated that the dysregulation of GUCA2A is a promising biomarker for accurate diagnosis and prognosis of CRC[44], and TSPAN1, a new member of the tetraspanin family, has also been shown to be highly involved in carcinogenesis and chemoresistance[45]. Here, TSPAN1 is linked to colorectal carcinoma.